Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Rapport Therapeutics, Inc.
Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update
August 08, 2024
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RAPP
Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on Pain
July 29, 2024
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RAPP
Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
June 12, 2024
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RAPP
Rapport Therapeutics Announces Pricing of Initial Public Offering
June 06, 2024
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
Rapport Therapeutics Appoints Pioneering Industry Leader John Maraganore to Board of Directors
March 19, 2024
From
Rapport Therapeutics, Inc.
Via
Business Wire
Rapport Therapeutics Appoints Chief People Officer
February 28, 2024
From
Rapport Therapeutics, Inc.
Via
Business Wire
Rapport Therapeutics Appoints Terry-Ann Burrell to Board of Directors
January 16, 2024
From
Rapport Therapeutics, Inc.
Via
Business Wire
Rapport Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Rapport Therapeutics, Inc.
Via
Business Wire
Rapport Therapeutics Appoints Chief Financial Officer
October 30, 2023
From
Rapport Therapeutics, Inc.
Via
Business Wire
Rapport Therapeutics Appoints Chief Operating Officer and Scientific Advisory Board Member
September 07, 2023
From
Rapport Therapeutics, Inc.
Via
Business Wire
Rapport Therapeutics Raises $150 Million in Series B Funding Round and Announces Key Board Appointments to Further Advance Precision Neuromedicine Platform
August 23, 2023
From
Rapport Therapeutics, Inc.
Via
Business Wire
Rapport Therapeutics Names Scientific Advisory Board
June 29, 2023
From
Rapport Therapeutics, Inc.
Via
Business Wire
Rapport Therapeutics Launches with $100 Million to Transform the Treatment of Neurological Disease through the Discovery and Development of Precision Therapies
March 07, 2023
From
Rapport Therapeutics, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.